See more : Cambria Africa plc (CMB.L) Income Statement Analysis – Financial Results
Complete financial analysis of Core Scientific, Inc. (CORZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core Scientific, Inc., a leading company in the Software – Infrastructure industry within the Technology sector.
- Qiagen N.V. (QGEN) Income Statement Analysis – Financial Results
- Haffner Energy S.A. (ALHAF.PA) Income Statement Analysis – Financial Results
- Starpharma Holdings Limited (SPHRY) Income Statement Analysis – Financial Results
- Riyadh Cement Co. (3092.SR) Income Statement Analysis – Financial Results
- China Eastern Airlines Corporation Limited (600115.SS) Income Statement Analysis – Financial Results
Core Scientific, Inc. (CORZ)
About Core Scientific, Inc.
Core Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It provides blockchain infrastructure, software solutions, and services. The company mines digital assets for its own account and provides hosting colocation services for other large-scale miners. It operates in two segments, Equipment Sales and Hosting. The company owns and operates computer equipment that is used to process transactions conducted on one or more blockchain networks in exchange for transaction processing fees rewarded in digital currency assets, commonly referred to as mining; and datacenter facilities to provide colocation and hosting services for distributed ledger technology, also commonly known as blockchain. It also develops blockchain-based platforms and applications, including infrastructure management, security technologies, mining optimization, and recordkeeping. The company is headquartered in Austin, Texas. On December 21, 2022, Core Scientific, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 502.40M | 640.31M | 544.48M | 60.32M | 59.52M |
| Cost of Revenue | 378.94M | 631.91M | 305.62M | 50.93M | 49.00M |
| Gross Profit | 123.46M | 8.40M | 238.86M | 9.39M | 10.53M |
| Gross Profit Ratio | 24.57% | 1.31% | 43.87% | 15.57% | 17.69% |
| Research & Development | 7.18M | 26.96M | 7.67M | 5.27M | 5.48M |
| General & Administrative | 93.91M | 213.28M | 60.49M | 14.55M | 13.78M |
| Selling & Marketing | 7.02M | 12.73M | 4.06M | 1.77M | 2.83M |
| SG&A | 100.93M | 226.01M | 64.55M | 10.40K | 16.61M |
| Other Expenses | 0.00 | -192.09M | -16.05M | -110.00K | 0.00 |
| Operating Expenses | 108.11M | 252.97M | 72.22M | 10.40K | 22.21M |
| Cost & Expenses | 487.05M | 884.89M | 377.84M | 10.40K | 71.21M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 235.00K |
| Interest Expense | 86.24M | 96.83M | 44.35M | 4.44M | 235.00K |
| Depreciation & Amortization | 96.45M | 226.09M | 33.36M | 9.40M | 6.12M |
| EBITDA | -63.12M | -1.84B | 167.61M | -10.40K | -4.64M |
| EBITDA Ratio | -12.56% | -2.89% | 36.73% | -0.02% | -7.79% |
| Operating Income | 8.96M | -244.57M | 166.64M | -10.40K | -10.76M |
| Operating Income Ratio | 1.78% | -38.20% | 30.61% | -0.02% | -18.07% |
| Total Other Income/Expenses | -254.77M | -53.86M | -68.42M | -5.88M | -235.00K |
| Income Before Tax | -245.80M | -2.16B | 63.08M | -10.40K | -11.92M |
| Income Before Tax Ratio | -48.93% | -337.87% | 11.58% | -0.02% | -20.03% |
| Income Tax Expense | 683.00K | -17.09M | 15.76M | -4.97M | 0.00 |
| Net Income | -246.49M | -2.15B | 47.31M | -10.40K | -11.92M |
| Net Income Ratio | -49.06% | -335.20% | 8.69% | -0.02% | -20.03% |
| EPS | -0.65 | -6.30 | 0.23 | 0.00 | -0.12 |
| EPS Diluted | -0.65 | -6.30 | 0.20 | 0.00 | -0.12 |
| Weighted Avg Shares Out | 379.86M | 340.65M | 207.26M | 43.13M | 98.68M |
| Weighted Avg Shares Out (Dil) | 379.86M | 340.65M | 233.31M | 43.13M | 98.68M |
7 Nasdaq Stocks to Sell Before They Die
7 Penny Stocks That Actually Have a Buy Rating
CORRECTING and REPLACING Core Scientific Announces Second Quarter 2022 Results
Bitcoin mining stocks record whopping gains in the last 30 days despite dull markets
Core Scientific, Inc.'s (CORZ) CEO Mike Levitt on Q2 2022 Results - Earnings Call Transcript
Core Scientific: A Buy On Leading Bitcoin Production Numbers
Why Core Scientific (CORZ) Might Surprise This Earnings Season
4 Hot Penny Stocks To Buy Based On Bullish Bets By Options Traders
Core Scientific, Inc. Schedules Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
Core Scientific Might Be Losing Out On 66 Percent Upside
Source: https://incomestatements.info
Category: Stock Reports